Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -0.34 |
peg ratio | -7.85 |
price to book ratio | 0.55 |
price to sales ratio | 19.45 |
enterprise value multiple | -0.67 |
price fair value | 0.55 |
profitability ratios | |
---|---|
gross profit margin | 50.81% |
operating profit margin | -5948.33% |
pretax profit margin | -5648.18% |
net profit margin | -5648.18% |
return on assets | -76.76% |
return on equity | -126.19% |
return on capital employed | -116.31% |
liquidity ratio | |
---|---|
current ratio | 3.02 |
quick ratio | 3.02 |
cash ratio | 0.90 |
efficiency ratio | |
---|---|
days of inventory outstanding | 0.00 |
operating cycle | 0.00 |
days of payables outstanding | 1,067.31 |
cash conversion cycle | -1,067.31 |
receivables turnover | 0.00 |
payables turnover | 0.34 |
inventory turnover | 0.00 |
debt and solvency ratios | |
---|---|
debt ratio | 0.00 |
debt equity ratio | 0.00 |
long term debt to capitalization | 0.00 |
total debt to capitalization | 0.00 |
interest coverage | -42.05 |
cash flow to debt ratio | 0.00 |
cash flow ratios | |
---|---|
free cash flow per share | -1.78 |
cash per share | 2.06 |
operating cash flow per share | -1.78 |
free cash flow operating cash flow ratio | 1.00 |
cash flow coverage ratios | 0.00 |
short term coverage ratios | 0.00 |
capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
Quoin Pharmaceuticals, Ltd. (QNRX) published its most recent earnings results on 08-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX)'s trailing twelve months ROE is -126.19%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Quoin Pharmaceuticals, Ltd. (QNRX) currently has a ROA of -76.76%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
QNRX reported a profit margin of -5648.18% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.02 in the most recent quarter. The quick ratio stood at 3.02, with a Debt/Eq ratio of 0.00.